H
Hu Lei
H指数:27
被引数:2,157
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Roles of JAMM-family deubiquitinase STAMBPL1 in cellular homeostasis and human cancer
JAMM家族去泛素化酶STAMBPL1在细胞稳态和人类癌症中的作用
Targeting USP47 reprograms macrophage polarization to ameliorate septic peritonitis and promote cutaneous wound healing
靶向USP47重编程巨噬细胞极化以改善脓毒症性腹膜炎并促进皮肤伤口愈合
USP2 in cancer: a double-edged sword and therapeutic target
USP2在癌症中:一把双刃剑和 therapeutic target
Identification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates
YL064作为ATXN3的新型抑制剂,通过促进癌源性底物的降解来抑制肿瘤生长和转移
Cell Death & Disease
IF9.6
TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma
TRMT1介导的tRNA m22G修饰通过ATXN3/USP25轴驱动奥希替尼耐药性在肺腺癌中的作用
Cell Death & Disease
IF9.6
Oxycodone versus Sufentanil for Postoperative Analgesia and Early Recovery After Radical Gastrectomy: A Propensity Score-Matched Study
奥曲哌替啶与舒芬太尼用于根治性胃切除术后的镇痛和早期康复:一项倾向性评分匹配研究
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia
一种可降解的多金属螯合的隐形纳米平台,用于在白血病中增强铁死亡/铜死亡的金属免疫疗法
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ
USP2通过稳定PPARγ促进代谢功能障碍相关脂肪性肝病的进展。
Sfrp2-deficient colonic fibroblasts drive mucosal inflammation and epithelial injury in ulcerative colitis
Sfrp2缺陷型结肠成纤维细胞驱动溃疡性结肠炎中的黏膜炎症和上皮损伤
Cellular Immunology
IF2.9
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4
428羟基可待因衍生物通过靶向GPX4抑制铁死亡
REDOX BIOLOGY
IF11.9
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells
鉴定USP2作为诱导骨髓瘤细胞中KRAS降解的新型靶点
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
重症儿科新型冠状病毒肺炎: 从临床和免疫病理生理学角度的回顾
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia
USP47稳定YBX1促进急性髓系白血病进展
ONCOGENE
IF7.3

